Dr Max Strengthens Serbian Presence with Zalfija Acquisition

Deal News | Jul 04, 2025 | CEE Legal Matters

Dr Max Strengthens Serbian Presence with Zalfija Acquisition

In a significant move towards expanding its footprint in Serbia, Dr Max has acquired Zalfija, a pharmacy chain with 30 retail outlets across the country. NKO Partners served as the legal advisor on this transaction. This is part of a broader acquisition strategy by Dr Max which has seen multiple purchases in the Serbian pharmaceutical sector over the years. Previously, Dr Max acquired VIVA Pharm, Ivancic i Sin, Miletic Plus, Pet-Sar Farm, and others in 2024 and 2023. The acquisition of Zalfija marks another step in consolidating Dr Max's market presence in Serbia's pharma industry.

Sectors

  • Pharmaceuticals
  • Legal Services

Geography

  • Serbia – The acquisition of Zalfija Pharmacy chain by Dr Max takes place in Serbia, enhancing its presence in the local market.

Industry

  • Pharmaceuticals – Dr Max's acquisition of Zalfija Pharmacy chain is part of its expansion strategy in the pharmaceutical industry.
  • Legal Services – NKO Partners has been a key legal advisor in Dr Max's acquisition strategy in Serbia, providing necessary legal counsel and services.

Financials

    Participants

    NameRoleTypeDescription
    Dr MaxBidding CompanyCompanyA leading pharmacy chain expanding its footprint in Serbia through strategic acquisitions.
    ZalfijaTarget CompanyCompanyA pharmacy chain in Serbia with 30 retail units.
    NKO PartnersLegal AdvisorCompanyA law firm advising Dr Max in its acquisition of Zalfija and other pharmacy chains.
    Djordje NikolicPartnerPersonA partner at NKO Partners involved in advising Dr Max.
    Branko JankovicPartnerPersonA partner at NKO Partners involved in advising Dr Max.
    Kristina StosicAssociatePersonAn associate at NKO Partners involved in advising Dr Max.